A Case of Advanced Non-Small-Cell Lung Cancer With Response to Alectinib and Favorable Quality of Life

Lung cancer is the leading cause of cancer death globally and in the United States. Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases. A progressive increase in morbidity and mortality is seen with advanced disease. Identifying specific driver mutations, such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Dhan B, Reddy, Vijay Ketan, Gaire, Suman, Kassem, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834647/
https://www.ncbi.nlm.nih.gov/pubmed/35165619
http://dx.doi.org/10.7759/cureus.21170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834647/
https://www.ncbi.nlm.nih.gov/pubmed/35165619
http://dx.doi.org/10.7759/cureus.21170

Ejemplares similares